Expression and phosphorylation of glutamate receptor subunits and CaMKII in a mouse model of Parkinsonism

Brain Research

Volumn 1549, Issue , 2014, Pages 22-31

  Koutsokera, Maria ^a   Kafkalias, Panagiotis ^a   Giompres, Panagiotis ^a   Kouvelas, Elias D ^a   Mitsacos, Ada ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

AMPA receptor; CaMKII; NMDA receptor; Parkinsonism; Protein phosphorylation; Weaver striatum

Indexed keywords

AMPA RECEPTOR; BETA TUBULIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; DOPAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GENOTYPE; IMMUNOBLOTTING; IMMUNOREACTIVITY; LOCOMOTION; MOUSE; NERVE CELL DEGENERATION; NERVE CELL PLASTICITY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; SUBSTANTIA NIGRA PARS COMPACTA;

AMPA RECEPTOR; CAMKII; NMDA RECEPTOR; PARKINSONISM; PROTEIN PHOSPHORYLATION; WEAVER STRIATUM;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; MICE; MICE, NEUROLOGIC MUTANTS; PARKINSONIAN DISORDERS; PHOSPHORYLATION; PROTEIN SUBUNITS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84893906553     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.12.023     Document Type: Article

References (79)

1. I.M. Araujo, S. Xapelli, J.M. Gil, P. Mohapel, A. Petersen, P.S. Pinheiro, J.O. Malva, B.A. Bahr, P. Brundin, and C.M. Carvalho Proteolysis of NR2B by calpain in the hippocampus of epileptic rats Neuroreport 16 2005 393 396
2. M. Awobuluyi, S.A. Lipton, and N.J. Sucher Translationally distinct populations of NMDA receptor subunit NR1 mRNA in the developing rat brain J. Neurochem. 87 2003 1066 1075
3. T.G. Banke, D. Bowie, H. Lee, R.L. Huganir, A. Schousboe, and S.F. Traynelis Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase J. Neurosci. 20 2000 89 102
4. A. Barria, and R. Malinow NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII Neuron 48 2005 289 301
5. S.A. Bayer, K.V. Wills, L.C. Triarhou, J.D. Thomas, and B. Ghetti Systematic differences in time of dopaminergic neuron origin between normal mice and homozygous weaver mutants Exp. Brain Res. 105 1995 200 208
6. X. Bi, J. Chen, and M. Baudry Calpain-mediated proteolysis of GluR1 subunits in organotypic hippocampal cultures following kainic acid treatment Brain Res. 781 1998 355 357
7. X. Bi, Y. Rong, J. Chen, S. Dang, Z. Wang, and M. Baudry Calpain-mediated regulation of NMDA receptor structure and function Brain Res. 790 1998 245 253
8. J.J. Bouyer, D.H. Park, T.H. Joh, and V.M. Pickel Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum Brain Res. 302 1984 267 275
9. A.M. Brown, A.Y. Deutch, and R.J. Colbran Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism Eur. J. Neurosci. 22 2005 247 256
10. P. Calabresi, R. Maj, A. Pisani, N.B. Mercuri, and G. Bernardi Long-term synaptic depression in the striatum: physiological and pharmacological characterization J. Neurosci. 12 11 1992 4224 4233
11. P. Calabresi, P. Giacomini, D. Centonze, and G. Bernardi Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity Ann. Neurol. 47 4 Suppl. 1 2000 S60 S68
12. P. Calabresi, B. Picconi, A. Tozzi, and M. Di Filippo Dopamine-mediated regulation of corticostriatal synaptic plasticity Trends Neurosci. 30 5 2007 211 219
13. P. Calabresi, M. Di Filippo, V. Ghiglieri, and B. Picconi Molecular mechanisms underlying levodopa-induced dyskinesia Mov. Disord. 23 Suppl. 3 2008 S570 S579
14. D. Centonze, P. Gubellini, B. Picconi, P. Calabresi, P. Giacomini, and G. Bernardi Unilateral dopamine denervation blocks corticostriatal LTP J. Neurophysiol. 82 6 1999 3575 3579
15. T.N. Chase, and J.D. Oh Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism Trends Neurosci. 23 Suppl. 10 2000 S86 S91
16. B.S. Chen, and K.W. Roche Regulation of NMDA receptors by phosphorylation Neuropharmacology 53 2007 362 368
17. W.S. Chen, and M.F. Bear Activity-dependent regulation of NR2B translation contributes to metaplasticity in mouse visual cortex Neuropharmacology 52 2007 200 214
18. G.L. Collingridge, R.W. Olsen, J. Peters, and M. Spedding A nomenclature for ligand-gated ion channels Neuropharmacology 56 2009 2 5
19. S.J. Coultrap, and K.U. Bayer CaMKII regulation in information processing and storage Trends Neurosci. 35 2012 607 618
20. J.T. Coyle MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia Proc. Natl. Acad. Sci. USA 106 2009 2975 2976
21. 2+/calmodulin- kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionate type glutamate receptors Proc. Natl. Acad. Sci. USA 96 1999 3269 3274
22. R. Dinglendine, K. Borges, D. Bowie, and S.F. Traynelis The glutamate receptor ion channels Pharmacol. Rev. 51 1999 7 61
23. A.W. Dunah, Y. Wang, R.P. Yasuda, K. Kameyama, R.L. Huganir, B.B. Wolfe, and D.G. Standaert Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-d-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease Mol. Pharmacol. 5 2000 342 352
24. 2+/calmodulin-dependent protein kinase in rat brain J. Neurosci. 5 12 1985 3270 3277
25. K. Fragioudaki, E.D. Kouvelas, R. Cristiani, P. Giompres, P. Bagnoli, and A. Mitsacos Expression of amino acid receptors and neural peptides in the weaver mouse brain Brain Res. 1140 2007 132 152
26. K. Fragioudaki, E.D. Kouvelas, and A. Mitsacos Differential effect of dopamine deficiency on the expression of NMDA receptor subunits in the weaver mouse brain Eur. J. Neurosci. 17 2003 2056 2064
27. T.F. Freund, J.F. Powell, and A.D. Smith Tyrosine hydroxylase- immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines Neuroscience 13 1984 1189 1215
28. F. Gardoni, B. Picconi, V. Ghiglieri, F. Polli, V. Bagetta, G. Bernardi, F. Cattabeni, M. Di Luca, and P. Calabresi A critical interaction between NR2B and MAGUK in l-DOPA induced dyskinesia J. Neurosci. 26 2006 2914 2922
29. K.R. Gogas Glutamate-based therapeutic approaches: NR2B receptor antagonists Curr. Opin. Pharmacol. 6 2006 68 74
30. L. Groc, L. Bard, and D. Choquet Surface trafficking of N-methyl-d-aspartate receptors: physiological and pathological perspectives Neuroscience 158 2009 4 18
31. R.P. Guttmann, D.L. Baker, K.M. Seifert, A.S. Cohen, D.A. Coulter, and D.R. Lynch Specific proteolysis of the NR2 subunit at multiple sites by calpain J. Neurochem. 78 2001 1083 1093
32. R.P. Guttmann, S. Sokol, D.L. Baker, K.L. Simpkins, Y. Dong, and D.R. Lynch Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ J. Pharmacol Exp. Ther. 302 2002 1023 1030
33. A. Hadj Tahar, L. Grégoire, A. Darré, N. Bélanger, L. Meltzer, and P.J. Bédard Effect of a selective glutamate antagonist on l-DOPA-induced dyskinesias in drug-naive parkinsonian monkeys Neurobiol. Dis. 15 2004 171 176
34. R.A. Hall, and T.R. Soderling Differential surface expression and phosphorylation of the N-methyl-d-aspartate receptor subunits NR1 and NR2 in cultured hippocampal neurons J. Biol. Chem. 272 1997 4135 4140
35. P.J. Hallett, A.W. Dunah, P. Ravenscroft, S. Zhou, E. Bezard, A.R. Crossman, J.M. Brotchie, and D.G. Standaert Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease Neuropharmacology 48 2005 503 516
36. P.J. Hallett, and D.G. Standaert Rationale for and use of NMDA receptor antagonists in Parkinson's disease Pharmacol. Ther. 102 2004 155 174
37. A.R. Halt, R.F. Dallapiazza, Y. Zhou, I.S. Stein, H. Qian, S. Juntti, S. Wojcik, N. Brose, A.J. Silva, and J.W. Hell CaMKII binding to GluN2B is critical during memory consolidation EMBO J. 31 2012 1203 1216
38. A.M. Hamilton, W.C. Oh, H. Vega-Ramirez, I.S. Stein, J.W. Hell, G.N. Patrick, and K. Zito Activity-dependent growth of new dendritic spines is regulated by the proteasome Neuron 74 6 2012 1023 1030
39. T. Klockgether, L. Turski, T. Honore, Z.M. Zhang, D.M. Gash, R. Kurlan, and J.T. Greenamyre The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys Ann. Neurol. 30 1991 717 723
40. J.R. Klug, B.N. Mathur, T.L. Kash, H.D. Wang, R.T. Matthews, A.J. Robison, M.E. Anderson, A.Y. Deutch, D.M. Lovinger, R.J. Colbran, and D.G. Winder Genetic inhibition of CaMKII in dorsal striatal medium spiny neurons reduces functional excitatory synapses and enhances intrinsic excitability PLoS One 7 2012 e45323
41. H.K. Lee Synaptic plasticity and phosphorylation Pharmacol. Ther. 112 2006 810 832
42. G.Y. Liao, D.A. Wagner, M.H. Hsu, and J.P. Leonard Evidence for direct protein kinase-C mediated modulation of N-methyl-d-aspartate receptor current Mol. Pharmacol. 59 2001 960 964
43. P.A. Löschmann, C. De Groote, L. Smith, U. Wüllner, G. Fischer, J.A. Kemp, P. Jenner, and T. Klockgether Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease Exp. Neurol. 187 2004 86 93
44. P.A. Löschmann, M. Kunow, and H. Wachtel Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease J. Neural Transm Suppl. 38 1992 S55 S64
45. P.A. Löschmann, K.W. Lange, M. Kunow, K.J. Rettig, P. Jahnig, T. Honore, L. Turski, H. Wachtel, P. Jenner, and C.D. Marsden Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with l-DOPA in models of Parkinson's disease J. Neural Transm. Park. Dis. Dement. Sect. 3 1991 203 213
46. Y.Y. Ma, C. Cepeda, and C.L. Cui The role of striatal NMDA receptors in drug addiction Int. Rev. Neurobiol. 89 2009 131 146
47. J. Marti, K.V. Wills, B. Ghetti, and S.A. Bayer The weaver gene continues to target late-generated dopaminergic neurons in midbrain areas at P90 Brain Res. Dev. Brain Res. 122 2000 173 181
48. J.E. Nash, S.H. Fox, B. Henry, M.P. Hill, D. Peggs, S. McGuire, Y. Maneuf, C. Hille, J.M. Brotchie, and A.R. Crossman Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease Exp. Neurol. 165 2000 136 142
49. J.G. Nutt, S.A. Gunzler, T. Kirchhoff, P. Hogarth, J.L. Weaver, M. Krams, B. Jamerson, F.S. Menniti, and J.W. Landen Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism Mov. Disord. 23 2008 1860 1866
50. J.D. Oh, D.S. Russell, C.L. Vaughan, and T.N. Chase Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration Brain Res. 813 1998 150 159
51. J.D. Oh, C.L. Vaughan, and T.N. Chase Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits Brain Res. 821 1999 433 442
52. R.V. Omkumar, M.J. Kiely, A.J. Rosenstein, K.T. Min, and M.B. Kennedy Identification of a phosphorylation site for calcium/calmodulin dependent protein kinase II in the NR2B subunit of the N-methyl-d-aspartate receptor J. Biol. Chem 271 1996 31670 31678
53. V. Paillé, B. Picconi, V. Bagetta, V. Ghiglieri, C. Sgobio, M. Di Filippo, M.T. Viscomi, C. Giampà, F.R. Fusco, F. Gardoni, G. Bernardi, P. Greengard, M. Di Luca, and P. Calabresi Distinct levels of dopamine denervation differentially alters striatal synaptic plasticity and NMDA receptor subunit composition J. Neurosci. 30 2010 14182 14193
54. N. Patil, D.R. Cox, D. Bhat, M. Faham, R.M. Myers, and A.S. Peterson A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation Nat. Genet. 11 1995 126 129
55. B. Picconi, D. Centonze, K. Håkansson, G. Bernardi, P. Greengard, G. Fisone, M.A. Cenci, and P. Calabresi Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia Nat. Neurosci. 6 2003 501 506
56. +2-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism J. Neurosci. 24 2004 5283 5291
57. B. Picconi, A. Tortiglione, I. Barone, D. Centonze, F. Gardoni, P. Gubellini, P. Bonsi, A. Pisani, G. Bernardi, M. Di Luca, and P. Calabresi NR2B subunit exerts a critical role in postischemic synaptic plasticity Stroke 37 2006 1895 1901
58. R. Raveendran, S. Devi Suma Priya, M. Mayadevi, M. Steephan, T.R. Santhoshkumar, J. Cheriyan, R. Sanalkumar, K.K. Pradeep, J. James, and R.V. Omkumar Phosphorylation status of the NR2B subunit of NMDA receptor regulates its interaction with calcium/calmodulin-dependent protein kinase II J. Neurochem. 110 2009 92 105
59. S. Roffler-Tarlov, B. Martin, A.M. Graybiel, S. John, and J.S. Kauer Cell death in the midbrain of the murine mutation weaver J. Neurosci. 16 1996 1819 1826
60. Y. Rong, X. Lu, A. Bernard, M. Khrestchatisky, and M. Baudry Tyrosine phosphorylation of ionotropic glutamate receptors by Fyn or Src differentially modulates their susceptibility to calpain and enhances their binding to spectrin and PSD-95 J. Neurochem. 79 2001 382 390
61. M. Sanhueza, G. Fernandez-Villalobos, I.S. Stein, G. Kasumova, P. Zhang, K.U. Bayer, N. Otmakhov, J.W. Hell, and J. Lisman Role of the CaMKII/NMDA receptor complex in the maintenance of synaptic strength J. Neurosci. 31 2011 9170 9178
62. M.J. Schmidt, B.D. Sawyer, K.W. Perry, R.W. Fuller, M.M. Foreman, and B. Ghetti Dopamine deficiency in the weaver mutant mouse J. Neurosci. 2 1982 376 380
63. J.R. Simon, and B. Ghetti The weaver mutant mouse as a model of nigrostriatal dysfunction Mol. Neurobiol. 9 1994 183 189
64. K.L. Simpkins, R.P. Guttmann, Y. Dong, Z. Chen, S. Sokol, R.W. Neumar, and D.R. Lynch Selective activation induced cleavage of the NR2B subunit by calpain J. Neurosci. 23 2003 11322 11331
65. P. Somogyi, J.P. Bolam, and A.D. Smith Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-peroxidase transport-degeneration procedure J. Comp. Neurol. 195 1981 567 584
66. I. Song, and R.L. Huganir Regulation of AMPA receptors during synaptic plasticity Trends Neurosci. 25 11 2002 578 588
67. A receptor balance by functional mesencephalic dopaminergic grafts in mice with hereditary Parkinsonism Exp. Neurol. 157 1999 259 267
68. S. Strack, R.B. McNeill, and R.J. Colbran Mechanism and regulation of calcium/calmodulin-dependent protein kinase II targeting to the NR2B subunit of the N-methyl-d-aspartate receptor J. Biol. Chem. 275 2000 23798 23806
69. S.F. Traynelis, L.P. Wollmuth, C.J. McBain, F.S. Menniti, K.M. Vance, K.K. Ogden, K.B. Hansen, H. Yuan, S.J. Myers, and R. Dingledine Glutamate receptor ion channels: structure, regulation and function Pharmacol. Rev. 62 2010 405 496
70. L.C. Triarhou, J. Norton, and B. Ghetti Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice Exp. Brain Res. 70 1988 256 265
71. A.M. VanDongen, and H.M. VanDongen Effects of mRNA untranslated regions on translational efficiency of NMDA receptor subunits Neurosignals 13 2004 194 206
72. C. Verney, A. Febvret-Muzerelle, and P. Gaspar Early postnatal changes of the dopaminergic mesencephalic neurons in the weaver mutant mouse Brain Res. Dev. Brain Res. 89 1995 115 119
73. H. Wachtel, M. Kunow, and P.A. Loschmann NBQX (6-nitro-sulfamoyl-benzo- quinoxalinedione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats Neurosci. Lett. 142 1992 179 182
74. J.Q. Wang, X. Liu, G. Zhang, N.K. Parelkar, A. Arora, M. Haines, E.E. Fibuch, and L. Mao Phosphorylation of glutamate receptors: a potential mechanism for the regulation of receptor function and psychostimulant action J. Neurosci. Res. 84 2006 1621 1629
75. R.H. Wessell, S.M. Ahmed, F.S. Menniti, G.L. Dunbar, T.N. Chase, and J.D. Oh NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats Neuropharmacology 47 2004 184 194
76. M.W. Wood, H.M. VanDongen, and A.M. VanDongen The 5'-untranslated region of the N-methyl-d-aspartate receptor NR2A subunit controls efficiency of translation J. Biol. Chem. 271 1996 8115 8120
77. L.J. Wu, and M. Zhuo Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain Neurotherapeutics 6 2009 693 702
78. K. Yashiro, and B.D. Philpot Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity Neuropharmacology 55 2008 1081 1094
79. Y. Zhou, E. Takahashi, W. Li, A. Halt, B. Wiltgen, D. Ehninger, G.D. Li, J.W. Hell, M.B. Kennedy, and A.J. Silva Interactions between NR2B receptor and CaMKII modulate synaptic plasticity and spatial learning J. Neurosci. 27 2007 13843 13853